COMPARATIVE DIAGNOSTIC VALUE OF DIFFERENT BIOMATERIALS FOR DETECTION OF TORCH PATHOGENS
DOI:
https://doi.org/10.55640/Keywords:
TORCH infections, congenital infections, biomaterials, molecular diagnostics, ELISA, PCR, prenatal screening.Abstract
TORCH infections represent a significant global health problem due to their association with congenital anomalies, fetal developmental disorders, and neonatal morbidity. The TORCH complex includes Toxoplasma gondii, Rubella virus, Cytomegalovirus (CMV), Herpes simplex virus (HSV), and other infectious agents capable of transplacental transmission during pregnancy. These pathogens can cause severe complications such as miscarriage, intrauterine growth restriction, congenital malformations, neurological impairment, and neonatal mortality.
The aim of this study was to evaluate the comparative diagnostic value of different biomaterials for the detection of TORCH pathogens. Various biological samples including blood serum, saliva, urine, placental tissue, and amniotic fluid were analyzed using modern laboratory diagnostic methods such as enzyme-linked immunosorbent assay (ELISA) and polymerase chain reaction (PCR).
The results demonstrated that molecular diagnostic methods, particularly PCR, provide significantly higher sensitivity and specificity compared with conventional serological testing. Non-invasive biomaterials such as saliva and urine showed high diagnostic value for detecting cytomegalovirus infection, whereas amniotic fluid analysis was particularly informative for detecting fetal infection caused by Toxoplasma gondii. The findings highlight the importance of selecting appropriate biomaterials and combining serological and molecular diagnostic techniques to improve early detection of TORCH infections.
Downloads
References
1.Adams Waldorf, K. M., & McAdams, R. M. (2019). Influence of infection during pregnancy on fetal development.
2.Brown, Z. A. (2021). Neonatal herpes simplex infection.
3.Cannon, M. J., Griffiths, P. D., & Aston, V. (2021). Universal screening for congenital cytomegalovirus infection.
4.Dunn, D., Wallon, M., Peyron, F., Petersen, E., Peckham, C., & Gilbert, R. (2020). Mother-to-child transmission of toxoplasmosis.
5.Fowler, K. B., Ross, S. A., & Boppana, S. B. (2018). Congenital cytomegalovirus infection.
6.Griffiths, P., Baraniak, I., & Reeves, M. (2019). Cytomegalovirus pathogenesis.
7.Kimberlin, D. W., & Whitley, R. J. (2020). Neonatal herpes infection.
8.Maldonado, Y. (2022). Congenital cytomegalovirus infection.
9.Neu, N., Duchon, J., & Zachariah, P. (2015). TORCH infections.
10.Rawlinson, W. (2017). Congenital cytomegalovirus infection in pregnancy.
Downloads
Published
Issue
Section
License

This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain the copyright of their manuscripts, and all Open Access articles are disseminated under the terms of the Creative Commons Attribution License 4.0 (CC-BY), which licenses unrestricted use, distribution, and reproduction in any medium, provided that the original work is appropriately cited. The use of general descriptive names, trade names, trademarks, and so forth in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations.

Germany
United States of America
Italy
United Kingdom
France
Canada
Uzbekistan
Japan
Republic of Korea
Australia
Spain
Switzerland
Sweden
Netherlands
China
India